Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | November 25, 2003 |
| Target | Pfizer s New Drug Application |
| Sector | Life Science |
| Buyer(s) | Andrx |
| Sellers(s) | Pfizer |
| Deal Type | Divestiture |
| Deal Value | 35M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 1,680 |
Andrx Corporation is engaged in the formulation and commercialization of oral controlled-release pharmaceuticals utilizing its proprietary drug delivery technologies. In its ANDA program, Andrx is developing bio-equivalent or generic versions of selected high sales volume controlled-release brand name pharmaceuticals.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2003 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| Deal Context for Seller | # |
|---|---|
| Overall | 4 of 19 |
| Sector: Life Science | 1 of 14 |
| Type: Divestiture | 4 of 15 |
| Country: United States | 3 of 13 |
| Year: 2003 | 1 of 1 |
| Size (of disclosed) | 10 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-04-16 |
Pharmacia
Peapack, New Jersey, United States Pharmacia Corp. a pharmaceutical and biotechnological company. |
Buy | $60.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-12-21 |
Esperion Therapeutics
Plymouth, Michigan, United States Development stage biotechnology company focused on cardiovascular drugs. Drug discovery and development company focused on therapies that prevent, treat and reverse cardiovascular and metabolic diseases. |
Buy | - |
